Use of angeloyl-substituted ingenanes in combination with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/22 (2006.01) A61K 36/47 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2629337

The present invention relates generally to therapeutic protocols for the treatment of cancer in subjects including humans. More particularly, the present invention provides a method for treating cancer comprising the administration of an angeloyl-substituted ingenane or a pharmaceutically acceptable salt, derivative, homolog or analog thereof and at least one other agent. Preferably, the latter agent is an anti-cancer agent or has or induces an anti-cancer effect.

La présente invention concerne de façon générale des protocoles thérapeutiques pour le traitement du cancer chez des sujets, y compris des humains. Plus particulièrement, la présente invention concerne une méthode de traitement du cancer comprenant l'administration d'un ingénane substitué par un groupement angéloyle ou d'un sel, dérivé, homologue ou analogue de qualité pharmaceutique de ce composé, en combinaison avec au moins un autre agent. De façon préférentielle, ce dernier est un agent anticancéreux, ou présente ou induit un effet anticancéreux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of angeloyl-substituted ingenanes in combination with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of angeloyl-substituted ingenanes in combination with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of angeloyl-substituted ingenanes in combination with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1588371

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.